668 related articles for article (PubMed ID: 15854489)
1. [Experimental study of dually targeting gene therapy system for pituitary adenomas].
Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489
[TBL] [Abstract][Full Text] [Related]
2. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
3. [Experimental studies on human lung cancer gene-therapy with HSV-TK/GCV system].
Sha H; Wang E; Bao G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):265-7. PubMed ID: 11326946
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of ovarian intra-arterial infusion of GE7-delivery system-mediated HSVl-tk/ganciclovir gene therapy in a rat model of malignant ovarian tumor].
Jiang W; Liu XX; Kang Y; Shao ZM; Zhou WJ; Gu JR; Xu CJ
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):245-8. PubMed ID: 22781033
[TBL] [Abstract][Full Text] [Related]
5. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
6. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
7. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
8. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
9. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
[TBL] [Abstract][Full Text] [Related]
10. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
12. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
13. [Procaspase-3 enhances in vitro effect of cytosine deaminase-thymidine kinase fusion disuicide gene therapy system on human ovarian carcinoma].
Song Y; Kong BH; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):411-6. PubMed ID: 16008895
[TBL] [Abstract][Full Text] [Related]
14. [Lethal effect of adenovirus-mediated HSV-TK gene in combination with hydroxycamptothecin on human bladder cancer in vitro].
Huang H; Tan WL; Zhu WH; Liang ZK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):461-4. PubMed ID: 17545031
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of polyethylenimine-mediated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3].
Jin P; Kong BH
Ai Zheng; 2005 Jul; 24(7):806-11. PubMed ID: 16004805
[TBL] [Abstract][Full Text] [Related]
16. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
Liu XP; Li BJ; Zhang C
Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].
Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
19. [In vitro killing effect of mutant thymidine kinase mediated by lentiviral vector on T lymphocytes].
Xu KL; Pan XY; Yang YJ; Lu QX; Li ZY; He XP
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):678-81. PubMed ID: 16620557
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of GE7-transferring system-mediated HSV(1)-tk gene transfer in a rat model of ovarian tumor via intra-arterial route].
Jiang W; Xu CJ; Shao ZM; Zhou WJ; Liu XX; Tian PK; Gu JR
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):4-7. PubMed ID: 21575455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]